Keyphrases
Abatacept
100%
Adverse Events
7%
Area under the Curve
15%
Autoimmune T Cells
7%
Autoimmunity
7%
Beneficial Effects
15%
Between-group
7%
Block Size
7%
C-peptide
23%
Cell Function
15%
Clinical Diagnosis
7%
Costimulation
100%
Costimulatory Molecules
7%
Double-blind Randomized Controlled Trial
7%
Geometric Mean
7%
Immunopathogenesis
7%
Intention-to-treat
7%
Meal Tolerance Test
7%
Neutropenia
7%
Peptide Concentration
7%
Permuted Block Randomization
7%
Placebo
46%
Randomized Placebo-controlled Trial
100%
Recent-onset
100%
Recently Diagnosed
7%
Research Personnel
7%
T Cell Activation
23%
T Cells
7%
Treatment Assignment
7%
Treatment Group
7%
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
100%
U.S. National Institutes of Health
7%
Medicine and Dentistry
Abatacept
100%
Adverse Event
7%
Autoimmunity
7%
C-Peptide
23%
Cell Function
15%
Co-Stimulation
100%
Immunopathogenesis
7%
Infection
7%
Infusion
30%
Insulin Dependent Diabetes Mellitus
100%
Intention-to-Treat Analysis
7%
Neutropenia
7%
Placebo
100%
Primary Outcome
7%
Randomized Controlled Trial
7%
T Cell
15%
T Cell Activation
23%
Treatment Group
7%